Prince Pharmaceutical Co., Ltd. Stock Price

TPEX:6935 Community·NT$1.0b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Author Program NEW Create Narrative

6935 Share Price Performance

NT$29.70

4.70 (18.80%)

NT$29.70

4.70 (18.80%)

NT$29.70

Mon, 3 Aug 26

Share Pricen/a

6935 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

No trending discussion available.

Snowflake Analysis

Flawless balance sheet and fair value.

1 Risk

2 Rewards

View Full Analysis

Prince Pharmaceutical Co., Ltd. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 2.63
: 21.07%
: 9.12%
: 35.4%

View Full Analysis

About 6935

Founded: 1962
Employees: 216
CEO: Da Li
WebsiteView website: www.prince-pharm.com.tw

Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin C tablets, vitamin B film-coated tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. Prince Pharmaceutical Co., Ltd. was founded in 1962 and is headquartered in Yúnlín, Taiwan.